Skip to content
Catalyst

knowcompoundsD-aspartic acid

Specimen compound organic compoundPlate I

D-aspartic acid

Nested hairline contours trace the electron density of one computed shape of D-aspartic acid, teal at the edge warming to amber over the atoms.
fig. 1D-aspartic acid · electron density · PubChem CID 83887, computed 3D conformer
Formula
C4H7NO4
Molar mass
133.103 g/mol
PubChem CID
83887
InChIKey
CKLJMWTZIZZHCS-UWTATZPHSA-N

↓ lowered

01 · the evidence, ordered

What the evidence says

Fig. 2 D-aspartic acid CHEBI:17364 1 endpoint its finding
×1.60
Labels
CompoundInspector

D-aspartic acid

7 reference statements, not drawn · 5 compounds on the outer ring, not drawn

Keys

← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it

02 · findings

What D-aspartic acid moved, and by how much

  • Dose studied: as its paper gave it.
  • Evidence strength: computed from the study. How it is computed
  1. Core body temperatureMoved: lowersEvidence: InsufficientPaper: PMID 248815182014
    Who
    chicks; rectal temperature monitored for 120 min after a single oral dose, under normal ambient temperature
    Dose studied
    0, 3.75, 7.5 and 15 mmol/kg body weight, oral

    Oral administration of D-Asp, but not of L-Asp, linearly decreased the rectal temperature in chicks.”

    Quoted verbatim from Oral administration of D-aspartate, but not L-aspartate, depresses rectal temperature and alters plasma metabolites in chicks.animal · not in humansPermalink

No dose is advised.

  • Dose studied: as its paper gave it.
  • Evidence strength: computed from the study. How it is computed

03 · identity

Structure

fig. 3D-aspartic acid · 2D structure · ChEBI’s SMILES
Charge
0
SMILES
N[C@H](CC(=O)O)C(=O)O

04 · reach

What it touches on the way

6 entities · assembled from reference reactions

  1. SLC1A3Protein63 paths · 59 endpointsinferred
  2. SLC1A2Protein48 paths · 45 endpointsinferred
  3. SLC1A1Protein30 paths · 30 endpointsinferred
  4. SLC1A6Protein8 paths · 8 endpointsinferred
  5. DDOProtein6 paths · 6 endpointsinferred
  6. SLC1A7Protein3 paths · 3 endpointsinferred

Where it reaches

20 regions · transporter routes

  1. Brainnervous4 routesinferred
  2. Airway and sinusesrespiratory2 routesinferred
  3. Blood vesselscardiovascular2 routesinferred
  4. Male reproductivereproductive2 routesinferred
  5. Nerve and spinal cordnervous2 routesinferred
  6. Skinintegumentary2 routesinferred
  7. Blood and immuneimmune1 routeinferred
  8. Colon and rectumdigestive1 routeinferred
  9. Eyenervous1 routeinferred
  10. Female reproductivereproductive1 routeinferred
  11. Gallbladderdigestive1 routeinferred
  12. Kidneyurinary1 routeinferred
Show the remaining 8Show the first 12
  1. Liverdigestive1 routeinferred
  2. Lungrespiratory1 routeinferred
  3. Pancreasendocrine1 routeinferred
  4. Skeletal musclemusculoskeletal1 routeinferred
  5. Small intestinedigestive1 routeinferred
  6. Spleenimmune1 routeinferred
  7. Stomachdigestive1 routeinferred
  8. Thyroidendocrine1 routeinferred

05 · documented · reference

Interactions

Documented interactions
None reported

Pairs that share biology

What the reference databases state

Reference statements
701 ProteinSLC1A1, SLC1A2, SLC1A3, SLC1A6, SLC1A7, DDO02 Compoundoxaloacetateinferred, one hop from D-aspartic acid
Reactions · Rhea
5reactions
7Reference statements

What the reference databases state

Evidence key

Statements

7 statements

5Reactions

06 · on the label · 176 products

Labelled products

Source: NIH DSLD · Ingredient: D-aspartic acid · 176 products · Declared amount per serving: 0.05–3,200 mg

124 labels state an amount52 do not

  • 1st PhormConquest HD3,120 mgper 6 capsulesDSLD:242739
  • 1st PhormConquest HD3,120 mgper 6 capsulesDSLD:323517
  • 5% CoreD-Aspartic Acid3,120 mgper 5 capsulesDSLD:333956
  • Absorb HealthD-Aspartic Acid160 mgper 0.167 ozsDSLD:215793
  • Achievements Through Science (ATS) LabsTest PSIamount not statedper 3 capsulesDSLD:297212
  • Advantage PharmaceuticalsAlpha T11,560 mgper 3 capsulesDSLD:36529
  • ALLMAX ESSENTIALSD-Aspartic Acid3.12 gper 3.12 gDSLD:296137
  • Anabolic Science LabsVital Test1,000 mgper 2 capsulesDSLD:259728
  • Anabolic WarfareProject Gains1 gper 3 capsulesDSLD:273270
  • Anabolic WarfareProject Ripped750 mgper 3 capsulesDSLD:272264
  • Anabolic WarfareProject Ripped750 mgper 3 capsulesDSLD:337977
  • Angry SupplementsHer Desire All Natural Sexual Healthamount not statedper 2 capsulesDSLD:264390
Show the remaining 164Show the first 12

Label record: NIH Office of Dietary Supplements · CC0

07 · the record

Sources

20

papers screened for D-aspartic acid

admitted
1
read and discarded
9
not read yet
10

The screening record, every paper and why

Sources cited

1 paper · 1 finding

Show every paper citedHide the papers cited

Other names · 5

(R)-2-aminobutanedioic acid · (R)-2-aminosuccinic acid · aspartic acid D-form · DAS

systematic · (2R)-2-aminobutanedioic acid